TARGRETIN

pharmaceutical preparations, namely, retinoids, for the treatment of skin related diseases, disorders of the eye, cancer and precancerous conditions, cardiovascular disorders, inflammatory diseases, neuro-degenerative diseases, and disorders related to the modulation of apoptosis